Skip to main content
$2.87 $0.02 (0.7%)

12:07 PM EST on 02/29/24

Leap Therapeutics, Inc. (NASDAQ:LPTX)

CAPS Rating: No stars

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer.

Current Price $2.87 Mkt Cap $72.9M
Open $2.99 P/E Ratio -0.50
Prev. Close $2.85 Div. (Yield) $0.00 (0.0%)
Daily Range $2.84 - $3.00 Volume 186,401
52-Wk Range $1.24 - $10.20 Avg. Daily Vol. 265,314

Caps

How do you think NASDAQ:LPTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

1 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:LPTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:LPTX Summary

  • Sector:
  • Industry:
  • Tags:

Fools bullish on NASDAQ:LPTX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about LPTX.

No one has written a Pitch for LPTX stock yet. Tell us why you think LPTX will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in LPTX.

Score Leader

HDTVBG

HDTVBG (67.13) Score: +53.24

The Score Leader is the player with the highest score across all their picks in LPTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ababrmon 27.91 6/23/2023 Outperform 5Y $4.11 -29.48% +16.78% -46.26 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for LPTX.